Insulin, functioning as a growth hormone by binding to the insulin-like growth factor receptor (IGF-R), has been linked to a more aggressive course of cancer in patients with type 2 diabetes mellitus (T2DM), as indicated by prior studies [30]. The gene discussed is GH1; the disease is type 2 diabetes mellitus.